Graf Akcie DGX (Quest Diagnostics, Inc.). Diskuze k akciím DGX. Aktuální informace DGX.

Základní informace o společnosti Quest Diagnostics, Inc. (Akcie DGX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 17.06B
Hodnota podniku (EV) 22.31B
Tržby 11.058B
EBITDA 2.895B
Zisk 2.247B
Růst v tržbách Q/Q 39.57 %
Růst v tržbách Y/Y 46.83 %
P/E (Cena vůči ziskům) 8.35
Forward P/E 13.17
EV/Sales 2.02
EV/EBITDA 7.71
EV/EBIT 7.19
PEG 1.24
Price/Sales 1.54
P/FCF 7.85
Price/Book 2.52
Účetní hodnota na akcii 56.45
Hotovost na akcii 9.67
FCF vůči ceně 12.74 %
Počet zaměstnanců 44,500
Tržba na zaměstnance 248.494k
Profit margin 15.16 %
Operating margin 24.47 %
Gross margin 38.50 %
EBIT margin 28.05 %
EBITDA margin 26.18 %
EPS - Zisk na akcii 17.06
EPS - Kvartální růst 123.94 %
EPS - Očekávaný růst příští rok -43.85 %
Return on assets 16.35 %
Return on equity 34.83 %
ROIC 15.34 %
ROCE 27.43 %
Dluhy/Equity 1.07
Čistý dluh/EBITDA 5.03
Current ratio 1.38
Quick Ratio 1.26
Volatilita 1.80
Beta 0.23
RSI 38.88
Cílová cena analytiků 142
Známka akcie (dle analytiků) 1.79
Insider ownership 0.50 %
Institutional ownership 92.54 %
Počet akcií 122.181M
Procento shortovaných akcií 7.57 %
Short ratio 8.46 %
Dividenda 2.42
Procentuální dividenda 1.70 %
Dividenda/Zisk 14.19 %
Obchodovaná od 1996
Země United States

Finanční výsledky akcie DGX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$9,437$7,726$7,531$7,402$7,214$7,493
Cost Of Goods Sold$5,804$5,037$4,926$4,719$4,616$4,657
Gross Profit$3,633$2,689$2,605$2,683$2,598$2,836
Research And Development Expenses------
SG&A Expenses$1,550$1,457$1,424$1,443$1,380$1,679
Other Operating Income Or Expenses$-9$95$10$-1$131$323
Operating Expenses$7,466$6,495$6,430$6,237$5,937$6,094
Operating Income$1,971$1,231$1,101$1,165$1,277$1,399
Total Non-Operating Income/Expense$-87$-155$-175$-135$-191$-296
Pre-Tax Income$1,884$1,076$926$1,030$1,086$1,103
Income Taxes$460$247$182$241$429$373
Income After Taxes$1,424$829$744$789$657$730
Other Income------
Income From Continuous Operations$1,499$886$788$824$696$753
Income From Discontinued Operations-$20----
Net Income$1,431$858$736$772$642$706
EBITDA$2,332$1,560$1,410$1,435$1,526$1,703
EBIT$1,971$1,231$1,101$1,165$1,277$1,399
Basic Shares Outstanding134134136137140144
Shares Outstanding136136139140142145
Basic EPS$10.62$6.36$5.39$5.63$4.58$4.92
EPS - Earnings Per Share$10.47$6.28$5.29$5.50$4.51$4.87
# 2020 2019 2018 2017 2016 2015
Current Ratio1.72181.25130.9361.23561.56071.2796
Long-term Debt / Capital0.37080.41090.39430.43070.44440.4256
Debt/Equity Ratio0.58970.83880.73910.76370.80130.7747
Gross Margin38.497434.804634.590436.24736.013337.8487
Operating Margin20.885915.933214.619615.73917.701718.6708
EBIT Margin20.885915.933214.619615.73917.701718.6708
EBITDA Margin24.711220.191618.722619.386721.153322.7279
Pre-Tax Profit Margin19.96413.92712.295813.915215.054114.7204
Net Profit Margin15.163711.10549.772910.42968.89949.4221
Asset Turnover0.67280.60160.68440.70480.71430.7522
Inventory Turnover Ratio26.026940.951249.757649.673756.292755.4405
Receiveable Turnover6.20867.26817.44178.01087.79058.3163
Days Sales In Receivables58.789950.219449.047945.563446.85243.8896
ROE - Return On Equity22.01515.579414.961116.629714.935615.9771
Return On Tangible Equity-121.7709-43.1564-31.4822-32.9732-30.4063-34.6048
ROA - Return On Assets10.68736.89877.16177.84546.89117.5587
ROI - Return On Investment13.85149.17859.06169.4688.29769.1773
Book Value Per Share51.195542.759439.014836.703734.014632.958
Operating Cash Flow Per Share5.6030.50660.24020.53372.1971-0.8482
Free Cash Flow Per Share5.47060.3208-0.71520.79711.9475-0.5379

Porovnání s konkurencí: Akcie DGX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
DGX 8.35 1.24 46.83 % -43.85 % 34.83 % 2.52 15.16 %
Akcie ENZ 24.19 N/A 54.87 % N/A % 12.38 % 2.52 6.69 %
Akcie LH 9.19 2.07 42.82 % -44.59 % 30.41 % 2.85 11.13 %
Akcie NEO 71.11 4.62 20.80 % -233.33 % 8.56 % 7.41 0.94 %
Akcie PMD 0.00 N/A -24.17 % N/A % -11.16 % 3.66 -18.07 %
Akcie TBIO 70.49 N/A 761.44 % -239.13 % 10.62 % 7.88 -38.75 %

Nedávné obchody insiderů: Akcie DGX

Jméno Obchod Cena Objem
Manner Carrie Eglinton
SVP and Advanced Diagnostics
Prodej
27 Apr 2020
$111.02 $555,100
Stephen H Rusckowski
Chairman, CEO, and President
Option
27 Apr 2020
$71.17 $833,899
Timothy M Ring
Director
Option
8 Jun 2020
$58.50 $686,205
Mark Guinan
Executive Vice President and CFO
Option
8 Jun 2020
$71.17 $5,166,657
Catherine T. Doherty
SVP and Group Exec. Clin. Fran.
Option
2 Sep 2020
$66.51 $3,883,652
Michael E Prevoznik
SVP and General Counsel
Option
14 Oct 2020
$52.17 $1,856,782
Stephen H Rusckowski
Chairman, CEO, and President
Option
16 Oct 2020
$66.51 $19,420,720
Michael J Deppe
Vice President, Corp. Controller, and CAO
Option
21 Oct 2020
$57.25 $598,263
Daniel Stanzione
Director
Prodej
23 Nov 2020
$126.30 $1,417,465
Gail R Wilensky
Director
Option
24 Nov 2020
$57.67 $352,421
Mark Guinan
Executive Vice President and CFO
Option
24 Dec 2020
$66.51 $5,437,592

Diskuze k akciím DGX